InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Cahill Brian Joseph, Chief Financial Officer. Insider active across 1 companies, notably Eagle Pharmaceuticals, INC.. Aggregated, 11 reports have been recorded. The latest transaction was disclosed on 28 February 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
08,000 shares0
Common Stock
SEC:0001209191-22-015022:0·
€32,153805 shares@ €39.941625.5% of flow
Common Stock
SEC:0001209191-22-007224·
€32,153805 shares@ €39.94160.98% mcap12.8% of flow
Common Stock
SEC:0001209191-22-007224:0·
€25,787626 shares@ €41.1930.78% mcap10.2% of flow
Common Stock
SEC:0001209191-22-006048:0·
€25,787626 shares@ €41.19320.5% of flow
Common Stock
SEC:0001209191-22-006048·
€11,787263 shares@ €44.81770.36% mcap4.7% of flow
Common Stock
SEC:0001209191-22-002882:0·
€11,787263 shares@ €44.81779.4% of flow
Common Stock
SEC:0001209191-22-002882·
€33,154738 shares@ €44.923526.3% of flow
Common Stock
SEC:0001209191-22-002417·
€33,154738 shares@ €44.92351.01% mcap13.2% of flow
Common Stock
SEC:0001209191-22-002417:0·
€23,019467 shares@ €49.290518.3% of flow
Common Stock
SEC:0001209191-21-070845·
€23,019467 shares@ €49.29050.70% mcap9.1% of flow
Common Stock
SEC:0001209191-21-070845:0·
11 of 11 declarations
About Cahill Brian Joseph
Brian Joseph Cahill is the Chief Financial Officer of EAGLE PHARMACEUTICALS, INC. He is responsible for the financial management of the company, including budgeting and financial reporting, to ensure its sustainable growth.
